We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.69B
AUM Growth
-$542M
Cap. Flow
-$781M
Cap. Flow %
-21.18%
Top 10 Hldgs %
56.86%
Holding
480
New
156
Increased
61
Reduced
86
Closed
113

Sector Composition

Rank Sector Weight
1 Healthcare 19.77%
2 Technology 14.28%
3 Consumer Staples 10.98%
4 Energy 9.87%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGS icon
301
PUT
B&G Foods
BGS
$267M
$128K ﹤0.01%
113,600
QURE icon
302
CALL
uniQure
QURE
$3.09B
$124K ﹤0.01%
80,000
+15,000
+23% +$202K
AMC icon
303
AMC Entertainment Holdings
AMC
$2.37B
$123K ﹤0.01%
39,688
BEAGR
304
Bold Eagle Acquisition Corp Right
BEAGR
$122K ﹤0.01%
+400,000
New +$116K
IFRX icon
305
InflaRx
IFRX
$327M
$119K ﹤0.01%
150,000
+91,927
+158% +$109K
QQQ icon
306
PUT
Invesco QQQ Trust
QQQ
$489B
$117K ﹤0.01%
20,000
+4,000
+25% +$1.99M
PTON icon
307
PUT
Peloton Interactive
PTON
$2.37B
$114K ﹤0.01%
400,000
+109,500
+38% +$711K
TLT icon
308
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
$102K ﹤0.01%
+600,000
New +$52.3M
STWD icon
309
PUT
Starwood Property Trust
STWD
$5.95B
$90.6K ﹤0.01%
172,500
INSP icon
310
PUT
Inspire Medical Systems
INSP
$1.82B
$85.5K ﹤0.01%
+10,000
New +$1.45M
BACQR
311
DELISTED
Inflection Point Acquisition Corp IV Right
BACQR
$81K ﹤0.01%
+250,000
New +$66.2K
SLNO
312
CALL
DELISTED
Soleno Therapeutics
SLNO
$74.5K ﹤0.01%
10,000
-5,000
-33% -$374K
IRM icon
313
PUT
Iron Mountain
IRM
$34.8B
$70K ﹤0.01%
+25,000
New +$2.36M
XBI icon
314
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$67.2K ﹤0.01%
+70,000
New +$5.58M
ALKS icon
315
PUT
Alkermes
ALKS
$7.73B
$58.1K ﹤0.01%
+25,000
New +$744K
TPH
316
PUT
DELISTED
Tri Pointe Homes
TPH
$57.1K ﹤0.01%
18,000
INCY icon
317
CALL
Incyte
INCY
$25.7B
$49.8K ﹤0.01%
35,000
-20,000
-36% -$1.27M
OMF icon
318
PUT
OneMain Financial
OMF
$7.44B
$45.6K ﹤0.01%
34,400
CAPR icon
319
PUT
Capricor Therapeutics
CAPR
$547M
$43.7K ﹤0.01%
+33,000
New +$349K
XLV icon
320
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44.1B
$40.6K ﹤0.01%
+70,000
New +$9.45M
SLNO
321
PUT
DELISTED
Soleno Therapeutics
SLNO
$40.2K ﹤0.01%
12,000
-6,000
-33% -$449K
BIIB icon
322
CALL
Biogen
BIIB
$32.6B
$30K ﹤0.01%
+20,000
New +$2.49M
FE icon
323
PUT
FirstEnergy
FE
$27.1B
$27.9K ﹤0.01%
26,000
CRSP icon
324
CALL
CRISPR Therapeutics
CRSP
$5.39B
$27.3K ﹤0.01%
+10,000
New +$387K
USO icon
325
PUT
United States Oil Fund
USO
$1.95B
$25.6K ﹤0.01%
+72,000
New +$5.03M

Similar funds

UBS O'Connor's Q2 2025 Portfolio in Review

As of Q2 2025, UBS O'Connor held 480 positions worth $3.69B, down 13% from $4.23B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor withdrew a net $781M in Q2 2025, closing 113 positions and reducing 86 holdings. Its most notable exit was Discover Financial Services, an estimated $408M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Skechers worth $227M.

  • UBS O'Connor's largest Q2 2025 buy was Skechers: 3,598,177 shares worth $227M.
  • UBS O'Connor added most to Blueprint Medicines in Q2 2025, an estimated $176M increase.
  • UBS O'Connor's biggest Q2 2025 reduction was Hess, cutting an estimated $251M.
  • UBS O'Connor fully exited Discover Financial Services in Q2 2025, selling an estimated $408M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.69B portfolio in Q2 2025.
  • UBS O'Connor opened 156 new positions and closed 113 in Q2 2025.
  • UBS O'Connor's portfolio value fell 13% quarter-over-quarter to $3.69B.

Based on UBS O'Connor's 13F filing for Q2 2025, filed 14 Aug 2025.